Table 1 Characteristics of the 110 localized prostate cancer patients
Characteristic | No. of patients (%) | |
|---|---|---|
Age | 52–79 (median 70.0) | |
Risk group | Low | 16 (14.5%) |
Intermediate | 46 (41.8%) | |
High | 48 (43.6%) | |
T-Stage (UICC 6th) | T1c-T2a | 81 |
T2b | 10 | |
T3a-T3b | 19 | |
Initial PSA value | <10 ng/mL | 60 (54.5%) |
10–19.9 ng/mL | 26 (23.6%) | |
≥20 ng/mL | 24 (21.8%) | |
Gleason score | 5–6 | 33 (30.0%) |
7 | 41 (37.3%) | |
8–10 | 36 (32.7%) | |
History of hormonal therapy | (−) | 76 (69.1%) |
(+) | 34 (30.9%) | |
Dose/fraction | 70 Gy/30 Fr(D95) | 101 |
75 Gy/30 Fr(Iso) | 5 | |
65.3 Gy/28 Fr(D95) | 3 | |
67.5 Gy/29 Fr(Iso) | 1 | |